Phocas Financial Corp’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
102,176
+15
| +0% | +$324 | 0.32% | 100 |
|
|
2025
Q1 | $1.7M | Sell |
102,161
-5,650
| -5% | -$93.8K | 0.26% | 107 |
|
|
2024
Q4 | $1.98M | Buy |
107,811
+47,596
| +79% | +$873K | 0.26% | 112 |
|
|
2024
Q3 | $926 | Sell |
60,215
-3,782
| -6% | -$58 | ﹤0.01% | 138 |
|
|
2024
Q2 | $1.04K | Sell |
63,997
-1,210
| -2% | -$20 | ﹤0.01% | 133 |
|
|
2024
Q1 | $1.21K | Sell |
65,207
-1,750
| -3% | -$32 | ﹤0.01% | 138 |
|
|
2023
Q4 | $2.1M | Buy |
66,957
+1,266
| +2% | +$39.6K | 0.28% | 115 |
|
|
2023
Q3 | $1.37M | Buy |
+65,691
| New | +$1.37M | 0.2% | 120 |
|